Kraft Michael D, Johnson Cary E, Chung Christopher, Julian Frank
College of Pharmacy, University of Michigan, Ann Arbor, USA.
Am J Health Syst Pharm. 2008 Apr 1;65(7):636-8. doi: 10.2146/ajhp070380.
The stability of metoprolol tartrate injection 1 mg/mL undiluted and 0.5 mg/mL in 0.9% sodium chloride injection and 5% dextrose injection was studied.
Sample set A contained 50 mL of Metoprolol Tartrate Injection, USP, 1 mg/mL transferred directly from the vials. Sample set B contained 50 mL of metoprolol 0.5 mg/mL diluted with 0.9% sodium chloride injection, and sample set C contained 50 mL of metoprolol 0.5 mg/mL diluted with 5% dextrose. All samples were prepared in triplicate and stored at room temperature. The stability of the samples was analyzed in duplicate using stability-indicating high-performance liquid chromatography immediately after preparation and at 6, 12, 18, 24, and 30 hours. The samples were assessed for pH and inspected for color and visible precipitation changes. The stability of metoprolol was determined by evaluating the percentage of the initial concentration remaining at each time interval. Stability of the product was defined as retention of 90% of the initial concentration.
The mean +/- S.D. initial concentration in sample sets A, B, and C was 1.006 +/- 0.009 mg/mL, 0.498 +/- 0.002 mg/mL, and 0.499 +/- 0.002 mg/mL, respectively. Throughout the 30-hour study period, at least 99% of the initial concentration of metoprolol tartrate remained in all three preparations at all time points. No appreciable changes in pH occurred. No changes in color and no visible precipitate or microbial growth were detected.
Metoprolol tartrate injection 1 mg/mL undiluted and 0.5 mg/mL in 0.9% sodium chloride injection and 5% dextrose injection were stable at room temperature for at least 30 hours.
研究酒石酸美托洛尔注射液1mg/mL未稀释状态、以及在0.9%氯化钠注射液和5%葡萄糖注射液中稀释成0.5mg/mL后的稳定性。
A组样品包含直接从小瓶中转移的50mL美国药典酒石酸美托洛尔注射液,浓度为1mg/mL。B组样品包含用0.9%氯化钠注射液稀释成0.5mg/mL的50mL酒石酸美托洛尔,C组样品包含用5%葡萄糖稀释成0.5mg/mL的50mL酒石酸美托洛尔。所有样品均一式三份制备,并在室温下储存。制备后立即以及在6、12、18、24和30小时时,使用稳定性指示高效液相色谱法对样品稳定性进行一式两份分析。对样品进行pH值评估,并检查颜色和可见沉淀变化。通过评估每个时间间隔剩余的初始浓度百分比来确定美托洛尔的稳定性。产品稳定性定义为保留初始浓度的90%。
A、B、C三组样品的平均±标准差初始浓度分别为1.006±0.009mg/mL、0.498±0.002mg/mL和0.499±0.002mg/mL。在整个30小时的研究期间,在所有时间点,所有三种制剂中酒石酸美托洛尔的初始浓度至少保留了99%。pH值没有明显变化。未检测到颜色变化、可见沉淀或微生物生长。
酒石酸美托洛尔注射液1mg/mL未稀释状态以及在含0.9%氯化钠注射液和5%葡萄糖注射液中稀释成0.5mg/mL后,在室温下至少30小时内是稳定的。